Trade Insight
    • Congress Trade
    • Insider Trade
    • Latest Trade
    • Congress Members
    • Corporate Insiders
More
  • TradeInsight.info LogoTradeInsight.info
    • FeaturesPricing
  • Sign InTry for Free
TradeInsight.info logo
TradeInsight.info
Formerly PelosiTrade.com
Operational
LinkedInGithubDiscord

Disclosures

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Product Updates

Knowledge

  • FAQ
  • Comparison guide
  • Security

Connect

  • About us
  • Contact
  • Careers

©2023-2025 TradeInsight.info. All rights reserved.

  • The content on this website is not intended as financial advice. Due diligence is required.
  • The date or time indicated here is given according to the US Eastern Time Zone.
  • The listed price is in USD and refers to the closing price on the specified trade date, before any adjustments due to stock splits or mergers, unless otherwise specified.
  • The Estimated Amount from Congress Trade is the midpoint of the trade value range from the report.
Cookie Notice

We use cookies to enhance your browsing experience.

Cookie Policy
  • 1/1
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.
Forgot your password?
Insider NameBuy/SellCompany NameTickerAmountShares Change
Nov 22, 2024Nov 26, 2024McMinn Rachel
CEO
BuyNeurogene Inc.NGNE$20.4$969,000+3.53%
Oct 02, 2017Oct 05, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$58.89$16,667-1.65%
Jul 31, 2017Aug 03, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$123.12$16,005-0.75%
Jul 03, 2017Jul 06, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$121.78$31,297-1.46%
May 01, 2017May 04, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$113.12$12,896-0.65%
Apr 03, 2017Apr 06, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$115$29,554-1.43%
Jan 03, 2017Jan 06, 2017McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$103.92$84,798-5.94%
Oct 31, 2016Nov 03, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$123.82$15,972-0.93%
Aug 01, 2016Aug 03, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$176.57$22,071-0.89%
Jul 05, 2016Jul 08, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$145.11$15,382-0.75%
May 02, 2016May 05, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$147.49$19,174-0.91%
Apr 04, 2016Apr 07, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$130.76$13,599-0.73%
Feb 01, 2016Feb 04, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$103.56$13,256-1.65%
Jan 04, 2016Jan 06, 2016McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$145.9$68,429-5.71%
Nov 02, 2015Nov 05, 2015McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$160.24$20,029-1.50%
Jul 31, 2015Aug 05, 2015McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$262.09$33,286-2.87%
May 01, 2015Jul 18, 2015McMinn Rachel
Chief Strategy Officer
SellIntercept Pharmaceuticals IncICPT$255.12$128,327-10.22%